Talk Presenting Companies (Theatre B) track
Drug Discovery and Development: Topia Life Science
Mon, Nov 9, 2026 · 4:15–4:30 PM CET Koelnmesse
About this session
Topia is an AI-powered drug discovery TechBio company that combines the development of NCEs and repurposed drugs with proprietary, patented technologies. We focus on targeted molecules addressing areas of high unmet medical need, with primary emphasis on cardio-metabolic disorders and central nervous system (CNS) diseases. We are advancing innovative therapies tackling the global epidemic metabolic and cardiovascular diseases, with our Rock2 program in Idiopathic Pulmonary Fibrosis (IPF)/MASH.
Speaker
-
CSO · Topia Life Science
Speaker